◀ Back to ARSA

ARSA — BTG2

Text-mined interactions from Literome

Carrieri et al., Stroke 1986 (Ischemic Attack, Transient) : We studied the effect of acetylsalicylic acid (ASA) versus placebo on B-thromboglobulin ( B-TG ) and platelet factor 4 (PF4) plasma levels and ADP induced platelet aggregation in 25 male patients with transient ischaemic attacks ( TIA ) ... ASA caused a significant reduction of B-TG plasma levels in TIA patients 2 hours after the first administration, but no effect was observed at the 7th and 14th day of treatment
Zatta et al., Agents Actions 1987 : At low PAF concentrations aggregation and BTG release were blocked by apyrase ( a scavenger of ADP ), by ASA ( an inhibitor of cyclooxygenase ) and by BM 13177 ( a thromboxane receptor antagonist )